Why the study?
Despite therapeutic advances, the pathophysiology of heart failure with preserved ejection fraction remains incompletely understood and markedly heterogeneous.
This review highlights the adipokine hypothesis, positioning systemic inflammation from visceral adipose tissue dysfunction as a central driver of HFpEF pathophysiology.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ideta et al. (2025) studied Heart Failure with Preserved Ejection Fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: